UBS Group AG - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 10 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$14,000
+600.0%
56,806
+685.2%
0.00%
Q1 2019$2,000
-84.6%
7,235
-75.1%
0.00%
Q4 2018$13,000
+1200.0%
29,007
+866.9%
0.00%
Q3 2018$1,000
-87.5%
3,000
-79.0%
0.00%
Q2 2018$8,000
+700.0%
14,316
+831.4%
0.00%
Q1 2018$1,000
-80.0%
1,537
-65.1%
0.00%
Q4 2017$5,000
+25.0%
4,400
+76.8%
0.00%
Q4 2016$4,000
-50.0%
2,488
-21.8%
0.00%
Q2 2016$8,000
+300.0%
3,180
+353.6%
0.00%
Q1 2016$2,000
-50.0%
701
-54.9%
0.00%
Q4 2015$4,000
-63.6%
1,556
-60.7%
0.00%
Q3 2015$11,0003,9640.00%
Other shareholders

There were no reported owners of EYEGATE PHARMACEUTICALS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of EYEGATE PHARMACEUTICALS INC shareholders